Immune Thrombocytopenia (ITP)

Similar documents
Immune Thrombocytopenic Purpura (ITP)

Haematology and Surgery Departments Splenectomy

The Oklahoma ITP Registry Newsletter July 2011

There are two main causes of a low platelet count

Treatment pathway for adult patients with immune (idiopathic) thrombocytopenic purpura (ITP)

QUICK REFERENCE Clinical Practice Guideline on the Evaluation and Management of Immune Thrombocytopenia (ITP)

Use of steroids in neurological conditions. Information for patients Pharmacy

Medicines Information

Evolution of clinical guidelines for ITP: Role of Romiplostim

Myeloma Haematology and Transplant Unit MPT

MEDICATIONS: THE GOOD, THE BAD, THE UGLY

What should I discuss with my health care provider before taking eltrombopag?

Diagnosis and Management of Immune Thrombocytopenias. Thomas L. Ortel, M.D., Ph.D. Duke University Medical Center 2 November 2016

Idiopathic Thrombocytopenic Purpura

Myeloma Haematology and Transplant Unit CTD1

Cardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE. Drug: AZATHIOPRINE Protocol number: CV 04

Scottish Medicines Consortium

Myeloma Haematology and Transplant Unit

Information on Azathioprine for Inflammatory Bowel Disease

Modified Ponticelli treatment record card

Haematology. R - CEPP Chemotherapy

Contemporary perspectives and initial management of pediatric ITP. William Beau Mitchell, MD Weill Cornell Medical College New York, NY USA

What is the most important information I should know about bortezomib? What should I discuss with my healthcare provider before receiving bortezomib?

The treatment is given every 3 weeks for 6 to 8 cycles.

Privigen solution for infusion

Factor XIII deficiency

Tripler Army Medical Center Obstetric Anesthesia Service - FAQs

For the Patient: ULUAVPMTN

PRESCRIBING GUIDELINE CONTROL PAGE. Title: Suspected or known Immune Thrombocytopenia Management Plan (Children) Version: 1 Reference Number: MMC-G117

Pemetrexed APOTEX Powder for Injection Contains the active ingredient pemetrexed (as disodium)

Cardiff & Vale (C&V) UHB Corporate Medicines Management Group (c MMG) SHARED CARE. Drug: MYCOPHENOLATE MOFETIL/SODIUM Protocol number: CV 15

High dose melphalan conditioning for autologous transplant (inpatient) Palatine treatment centre

13. Behçet s - In Children

ChIVPP. ChIVPP. Day 1 to 14 Chlorambucil tablets Procarbazine capsules Prednisolone tablets

Factor XI deficiency. Information for families. Great Ormond Street Hospital for Children NHS Foundation Trust

Rituximab for the treatment of adults with idiopathic (immune) thrombocytopenic purpura (ITP)

For the Patient: Adjuvant therapy for breast cancer using weekly paclitaxel and trastuzumab (Herceptin)

Hospital No. Weston Park Hospital contact number

PATIENT INFORMATION LEAFLET

Scottish Medicines Consortium

GCVP. Cyclophosphamide by injection Vincristine by short infusion. Gemcitabine by infusion over 30 minutes

For the Patient: LUAVPP (Carboplatin Option)

Rituximab treatment in autoimmune blistering diseases

Haematology. The other 2 drugs, folinic acid and GCSF, help to reduce the side effects of the treatment.

The ITP Patient Advocate

LUPUS. and Medication LUPUSUK 2015

Leukemia. There are different types of leukemia and several treatment options for each type.

Clinical Commissioning Policy Proposition: Rituximab for cytopaenia complicating primary immunodeficiency

Methotrexate in Inflammatory Bowel Disease. An information guide

GOOD MORNING! Thursday, July Heidi Murphy, MD Leslie Carter-King, MD

Pentostatin (Nipent )

Dexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop.

Factor X deficiency. Information for families. Great Ormond Street Hospital for Children NHS Foundation Trust

Methotrexate. About This Drug. Possible Side Effects. Warnings and Precautions

Dr Kannan S Consultant Hematologist Sahyadri Speciality Hospital, Pune K E M Hospital, Pune

Rituximab: A drug Information Sheet

I M VACCINATING FOR TWO NOW. IT S A LIFESAVER. Pregnant women and their babies are at risk from flu. Protect you and your baby - get your flu vaccine.

For the Patient: Alemtuzumab SC injection Other names: MABCAMPATH, CAMPATH

Adalimumab for Inflammatory Bowel Disease. An information guide

Pain Relief Options for Labor. Providing you with quality care, information and support

For the Patient: PROTOCOL SMAVTMZ Other Names: Palliative Therapy for Malignant Melanoma with Brain Metastases Using Temozolomide

Haematology Mycophenolate Mofetil Information for patients

Dr. MUBARAK ABDELRAHMAN MD PEDIATRICS AND CHILD HEALTH Assistant Professor FACULTY OF MEDICINE -JAZAN

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

If your IBD has not been well controlled, or is flaring up quite often, methotrexate may be added to your treatment.

Cyclophosphamide Treatment (To be used in conjunction with the Shared Care Blood Test Monitoring Card)

What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide

Appendix to Notification Letter for rituximab and eltrombopag dated 20 February 2014

Novel oral anticoagulant therapy (NOAC)

Technology appraisal guidance Published: 27 April 2011 nice.org.uk/guidance/ta221

Leflunomide Treatment Rheumatology Patient Information Leaflet

Package leaflet: Information for the user innohep 20,000 IU/ml tinzaparin sodium

Department of Clinical Haematology. Chemotherapy. Information for patients. Page 1 of 12

Direct Oral Anticoagulant (DOAC)Therapy. Important information for patients prescribed: Apixaban, Dabigatran, Edoxaban or Rivaroxaban

Thrombosis and Anticoagulation Team. Warfarin. Information for patients, relatives and carers

ALL Consolidation (cycles 1-4)

Package Leaflet: Information for the User Mercaptopurine 50mg tablets 6-mercaptopurine

For the Patient: Rituximab injection Other names: RITUXAN

Expert Review: Updates in Immune Thrombocytopenia. Reference Slides

Henoch-Schӧnlein Purpura (HSP) Child Health Patient Information Leaflet

THE OLD AND THE NEW OF ITP. Alison Street Malaysia April 2010

V.N. KARAZIN KHARKOV NATIONAL UNIVERSITY

Infliximab for Inflammatory Bowel Disease. An information guide

Factor VII deficiency

Tocilizumab Tocilizumab

Prophylaxis of acute transplant rejection in patients receiving allogeneic renal transplants:

For the Patient: Neoadjuvant therapy for locally advanced breast cancer using weekly paclitaxel followed by doxorubicin and cyclophosphamide

Intravenous anti-cancer treatment

Gammaplex 2.5 g, 5 g, 10 g and 20 g 5% w/v solution for infusion human normal immunoglobulin

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

4. Behçet s - Treatment

Azathioprine Shared Care Guideline for GPs

(pack li TAX ell) For treating breast cancer, lung cancer, ovarian cancer, Kaposi's sarcoma or other cancers

Obinutuzumab (lymphoma) Obinutuzumab (lymphoma)

Understanding Adalimumab

Things to Know When Taking Warfarin (Coumadin ) Anticoagulation Therapy

Understanding Methotrexate

Eloxatin Oxaliplatin concentrated solution for injection

Know About ITP. This document is to be viewed on only. Contents

Haematology. C = Cyclophosphamide (pronounced sigh clo fos fa mide)

Transcription:

Immune Thrombocytopenia (ITP)

ITP - What is it? ITP is a blood disorder affecting platelets in the blood. Platelets are small cells in your blood that help your blood to clot. In ITP the body s immune system produces antibodies which destroy platelets. Thrombocytopenia refers to a reduced number of platelets. The normal range of the platelet count is usually expressed as between 150-400. People with ITP have a reduced platelet count but the way they function is normal. Purpura refers to the purple bruising under the skin and mucous membranes, such as the lining of the mouth. Who does it affect? ITP can affect both children and adults. It can be both acute and chronic. It may affect both men and women. Adults with ITP How is it diagnosed? A medical history will be taken looking at a history of bleeding. A drug history is also taken, as some drugs may affect your platelet count. A physical examination is carried out. A blood count is taken and a blood film (slide) is examined under the microscope. A test for the presence of Helicobacter Pylori (an infection that may be found in the gut) may be taken and if positive, medication may be given to help resolve the problem. A bone marrow test may be performed. Symptoms may vary from people with mild bruising and bleeding to those who have more serious bleeding episodes. Head injuries or ongoing headaches should always be treated seriously and medical help sought urgently. What treatment is available? In general, people with platelet counts exceeding 30 require no treatment unless they need any interventions that may be associated with blood loss, such as surgery, dental extraction or childbirth. Prednisolone (oral steroid) is usually the initial treatment. Two thirds of patients will respond to prednisolone at a dose of 1mg/kg/day for 2-4 weeks reducing the dose gradually over several weeks. Side effects may include: weight gain, gastric irritation, disturbed sleep patterns and possibly increased risk of infection.

You should always let your doctor know if you are unwell and taking steroids. Long-term complications may include thinning of the bones and the development of diabetes. Intravenous immunoglobulin (IVIG) may be used and is effective in three quarters of cases. Response may be short-lived and the platelet count may start drifting back down in 3-4 weeks. It is useful to know if people respond to IVIG as it can be used to cover surgical procedures. How it works is not fully understood. It is a blood product. Several steps have been taken by the manufacturer to reduce the risk of blood-borne viruses to extremely low levels. Splenectomy (removal of the spleen) is an option and 2/3rds of people with ITP who undergo it will achieve a normal platelet count with no additional treatment. Some people will receive a partial or passing response. The spleen plays an infection-fighting role and as a result there is a need for pre-operative vaccinations and post operatively life-long antibiotics. Predicting the response to splenectomy is individual and your doctor will discuss this with you. Your surgeon will discuss the actual surgery with you. Dexamethasone (steroid) may be used as a four-day cycle at a dose of 40mg orally a day. The cycle may be repeated every 28 days for 6 cycles. Methylprednisolone (steroid) is also used. This is given as an intravenous infusion over 30-60 minutes as an outpatient. Nplate (Romiplostim) is a drug used to treat adult patients with chronic ITP, who are resistant to other therapies. It works by stimulating the bone marrow to produce more platelets. It is given by a weekly subcutaneous (under the skin) injection and requires regular monitoring of platelet counts and possible dose alteration. If Nplate is stopped your platelet count is likely to fall. This drug is not used as first line therapy. Eltrombopag (Revolade) belongs to a group of medicines called thrombopoietin receptor agonists. It is used to help increase the number of platelets in your blood. It is given orally and has some dietary restrictions. Rituximab is a drug that has proved useful for some patients. It is given as an infusion weekly for 4 weeks. A pre-medication is given to help reduce possible side-effects. Immunosuppressive therapies may be used in people who do not respond to other therapies. Mycophenolate mofetil, azathioprine or cyclophosphamide may be used. Signs and symptoms that need action: Head injury or other severe injury. Nose/mouth bleeds that do not stop with usual first aid. Headaches that do not resolve.

Seek advice: If you notice blood in your urine or stool. If your periods are heavier than normal. If you notice that you are bruising for no reason. If you notice petechiae a rash of red, pin-prick sized spots. You need to have a full blood count taken and then you will be referred appropriately, depending on the result. Do not take aspirin or non steroidal antiinflammatory drugs, such as Nurofen ibuprofen, unless discussed with your doctor first. Children with ITP Acute ITP is often seen in young children, sometimes following a viral infection. The onset is usually sudden. About 80% of children with ITP will recover spontaneously within 6-8 weeks without any intervention. Chronic ITP refers to an episode which lasts longer than 6-8 weeks. Many children settle with an adequate platelet count i.e. more than 20 and have no symptoms unless injured. Children who are under 10 years of age at the time of diagnosis are likely to have a spontaneous remission. Children over 10 years of age at diagnosis, and in particular adolescent females, are more likely to sustain a chronic course and are managed similarly to adults with the condition. How is it diagnosed? A full blood count may be taken and examined. Other blood tests may be taken to exclude any other diagnosis. Occasionally a bone marrow biopsy may be required to assist with the diagnosis. A full drug history will be taken as some drugs may affect platelet production. When is treatment required? More than 80% of children with ITP do not have significant bleeding symptoms and they do not require specific interventions. What treatment is available if needed? Corticosteroids are generally first-line treatment. They may be given orally as prednisolone or intravenously as methylprednisolone. They are given at high doses but for short periods. Side effects may include: Increased appetite and weight gain Disturbed sleep pattern, mood changes.

Stomach irritation. Increased susceptibility to infection. Always let your doctor know that you are taking steroids. With long-term use, other side effects may develop such as diabetes and thinning of the bones. The use of long-term steroids is generally avoided. Intravenous immunoglobulin (IVIG) may be used. This is given as an infusion in hospital over a few hours. It is a blood product and reactions may occur. During manufacture precautions are taken against blood-borne infections but they cannot be completely eliminated. Patients may receive a pre-medication in order to help prevent this. If patients respond to treatment IVIG may be used to cover surgical/dental procedures. Splenectomy may be considered in some children. Long-term responses may vary and the problem may return. Do not take aspirin or non steroidal anti-inflammatory drugs, such as ibuprofen (Nurofen), unless you have discussed it with your doctor. ITP in pregnancy Mild to moderately low platelets are not uncommon in pregnancy. Platelet count tends to fall in the later stages of pregnancy to 120-150 (normal range 150-400). The reason for this gestational thrombocytopenia is unknown. It seldom causes problems for either the baby or the mother and the count usually returns to normal once the baby is born. The mother with ITP How is it diagnosed? A full blood count is taken and a blood film (slide) examined under the microscope. Various other blood tests are taken, to exclude other causes of low platelets. Diagnosis is largely one of exclusion. A bone marrow biopsy is not usually performed. What treatment is available? Treatment is based on the risk of bleeding. The platelet count may fall as the pregnancy progresses. Therefore careful planning is needed to ensure a safe count at the time of delivery. If you have no bleeding symptoms and the platelet count is 20 or greater then no treatment is needed until delivery is imminent, but careful blood monitoring is required. Platelet counts of 50 or more are regarded as safe for normal vaginal delivery. Platelet counts of 50 are also safe for a Caesarean delivery, but epidural anaesthesia would be avoided. The platelet count should be 80 for this.

If the duration of treatment is likely to be short then prednisolone, a steroid may be used at a dose of 1mg/kg/day based on pregnancy weight with the dose gradually being reduced. Side effects may include: increased appetite and weight gain, mood changes, disturbed sleep pattern, possible increase in infection risk, blood pressure and blood sugars will be monitored. Diabetes and thinning of the bones may be a problem with long-term use. Steroids are broken down by the placenta and will not usually have any significant effect on the baby. Intravenous immunoglobulin (IVIG) may also be used, doses may vary. It is a blood product and is usually given with pre-medication under supervision and over a few hours. The manufacturer takes precautions against blood borne infections but they cannot be completely eliminated. What happens if I do not respond to treatment? High dose methylprednisolone (intravenous steroid) may be used in combination with IVIG and/or immunosuppression therapy. How will my baby be delivered? The obstetrician will advise on the safest method of delivery and pain relief looking at platelet count and any previous delivery history. Caesarean or vaginal delivery will be determined by obstetric indicators rather than the ITP history alone. The baby ITP is not an inherited condition. However it is possible that the mother s antibodies have crossed the placenta, entering the baby s blood and the baby may have a lower platelet count for the first few weeks or so after birth. A cord blood platelet count should be taken. If the platelet count is low, daily platelet counts should be taken from the baby until a rise is seen, usually day 2-5 post birth. Breastfeeding there is no reason why you cannot breast feed your baby. Non steroidal anti-inflammatory drugs, such as Nurofen, ibuprofen, should be avoided whilst the platelet count is below 100.

Treatment Record Name. Date of Birth.. Normal platelet range: 150-400 Date Treatment Course Outcome

Clinic Discharge Advice When you are discharged from the haematology clinic, the alert signs that you need to be aware of are: Increased or unusual signs of bleeding or bruising. A rash of pin prick sized spots (petechiae). If your menstrual periods are heavier or longer than usual. Increased nose or gum bleeds. Unresolved headaches. In the first instance, a full blood count should be taken and depending upon the result your General Practitioner may refer you back to the Haematology Department. Where to get information: Haemostasis/Thrombosis Clinical Nurse Specialist Voicemail: (01803) 655270 E-mail: fiona.dooley@nhs.net ITP Support Association: send an A5 envelope with 2 first class stamps to: The ITP Support Association Synehurste Kimbolton Road Bolnhurst Bedfordshire MK44 2 EW www.itpsupport.org.uk 23569 V1/Haematology/TSDFT/08.17/Review Date 08.19